北京中医药大学东直门医院 北京 100700
张静娴,女,在读硕士生
# 田劭丹,女,博士,主任医师,副教授,博士生导师,主要研究方向:中西医结合防治恶性肿瘤,E-mail:oliviatsd@126.com
纸质出版日期:2023-05-30,
网络出版日期:2023-03-03,
收稿日期:2022-10-11,
移动端阅览
张静娴, 陈信义, 田劭丹. 益血生胶囊基于肾主骨生髓化血理论治疗贫血的临床实践[J]. 北京中医药大学学报, 2023,46(5):731-735.
ZHANG Jingxian, CHEN Xinyi, TIAN Shaodan. Clinical application of
张静娴, 陈信义, 田劭丹. 益血生胶囊基于肾主骨生髓化血理论治疗贫血的临床实践[J]. 北京中医药大学学报, 2023,46(5):731-735. DOI: 10.3969/j.issn.1006-2157.2023.05.021.
ZHANG Jingxian, CHEN Xinyi, TIAN Shaodan. Clinical application of
基于中医藏象理论,对《黄帝内经》“肾主骨,生髓,髓生血”理论之间的相关性进行阐释,论述其与西医学各类贫血之间的病理关系,并回顾补肾法治疗贫血理论体系的渊源,以及多位名老中医对补肾法治疗再生障碍性贫血等疾病的见解与认识。同时,基于方、证、药对应理论,以补肾法治疗再生障碍性贫血、缺铁性贫血的典型中成药益血生胶囊为例,按照中医药理论对其组方进行解析,总结其现代基础研究及临床应用疗效。通过益血生胶囊相关文献整理与分析表明,益血生胶囊治疗贫血效果佳,不良反应少,具有较好的临床推广应用价值,进一步证明肾主骨生髓化血理论的科学性和实用性,为再生障碍性贫血、缺铁性贫血、妊娠贫血等各类贫血的临床治疗提供重要的背景资料。
Based on the theory of visceral manifestation in traditional Chinese medicine
this paper explains the correlation between the theory of "the kidney rules bone
generates marrow
and marrow generates blood" in
Huangdi Neijing;
discusses the pathological relationship with various types of anemia in western medicine; and reviews the origin of the theoretical system of kidney-nourishing therapy in treating anemia
as well as the views and recognition of many famous veteran doctors of traditional Chinese medicine on kidney-nourishing therapy in treating aplastic anemia and other diseases. At the same time
based on the theory of corresponding among prescriptions
syndromes and medicines
and taking the typical Chinese patent medicine
Yixuesheng
Capsule
which is used to treat aplastic anemia and iron deficiency anemia with kidney-nourishing therapy
as an example
the composition of the prescription is analyzed according to the theory of traditional Chinese medicine
and its modern fundamental research and clinical application effects are summarized. According to the collation and analysis of relevant literature on
Yixuesheng
Capsule
it is shown that
Yixuesheng
Capsule has a good effect in treating anemia with few adverse reactions
and it has a good clinical application value
which further proves the scientific and practical nature of the theory of kidney rules bone
generates marrow
and marrow generates blood
and can provide important background information for guiding the clinical treatment of various forms of anemia
such as aplastic anemia
iron deficiency anemia
and pregnancy anemia.
肾藏象肾主骨肾生髓髓生血贫血
kidney visceral manifestationkidney rules bonekidney generates marrowmarrow generates bloodanemia
付秋月,王小平.“肾生血”及肾血虚证理论探讨[J].江苏中医药,2021,53(8):31-34.
张金生,张宝霞.“肾精”与“干细胞”的同一性认识[J].中华中医药学刊,2018,36(2):326-328.
杨桂莲,陈明.从现代医学角度认识中医“肾主骨”之理论内涵[J].内蒙古中医药,2016,35(17):159.
孔圆,黄晓军.造血调控的新机制与新干预[J].生物医学转化,2020,1(1):21-25.
阮冬冬,袁军,曾毅,等.基于“肾生髓,髓生血”理论探讨肾性贫血的机制与治疗[J].世界中西医结合杂志,2021,16(10):1948-1951.
顾恪波,程艳玲,孙玉雯,等.吴志奎“益髓生血”理论治疗地中海贫血应用及机制[J].北京中医药,2021,40(4):386-388.
周江.陈绍宏运用龟鹿二仙胶治疗慢性再生障碍性贫血的经验[J].世界中医药,2008,3(2):88.
于孙婉琪,谷梦宇,史文萱,等.孙伟正教授从肾论治非重型再生障碍性贫血经验撷英[J].中医药信息,2022,39(3):25-28.
王珊,陈建玲,孙继生,等.健脾补肾活血法联合小剂量雄激素治疗慢性再生障碍性贫血临床观察[J].光明中医,2019,34(24):3807-3809.
陈信义,陈珮.中医治疗血液病名家学术观点撷菁[J].北京中医药,2021,40(5):466-469.
孙伟正,于材声.以补肾中药为主治疗再生障碍性贫血215例的生存率及远期疗效分析[J].中医杂志,1988,29(4):27-30.
孙伟正,王祥麒,袁斌华,等.补髓生血胶囊治疗慢性再生障碍性贫血的临床观察[J].中国中西医结合杂志,1997,17(8):467-469.
朱跃岚,孙伟正.补髓生血胶囊治疗慢性再生障碍性贫血临床研究[J].北京中医药大学学报,1998,21(5):48-49.
赵新广,刘丹卓,孙伟正.再生障碍性贫血病因及分型探讨[J].国医论坛,2000,15(3):19-20.
雍彦礼,孙凤.补髓生血颗粒对慢性髓劳病IL-21和IL-21 mRNA的影响[J].世界中西医结合杂志,2019,14(10):1339-1341.
刘忠义,李伟,陈颖丽,等.益血生抗贫血作用的实验研究[J].白求恩医科大学学报,2000, 26(2):178.
张平.益血生胶囊联合兔抗人胸腺细胞免疫球蛋白治疗再生障碍性贫血的临床研究[J].现代药物与临床,2018,33(7):1751-1754.
吴晓芳,张向慧.益血生胶囊联合小剂量环孢菌素A和司坦唑醇治疗慢性再生障碍性贫血效果观察[J].卫生职业教育,2017,35(5):138-139.
史启霞.益血生胶囊联合蔗糖铁对缺铁性贫血患者血清铁蛋白、血清铁水平的影响[J].吉林医学,2021,42(3):583-585.
俞红丽,孙金明.益血生胶囊治疗缺铁性贫血48例[J].陕西中医,2006,27(5):542-543.
谭伟兰,曾秋霞,区凯敏.蛋白琥珀酸铁口服溶液联合益血生胶囊治疗妊娠期缺铁性贫血疗效评价[J].中国药业,2020,29(5):146-148.
王娜,陈丽珍,邱雪洲,等.益血生胶囊联合多糖铁复合物治疗妊娠期缺铁性贫血的临床研究[J].现代药物与临床,2021,36(6):1190-1193.
赵琳,李虹,崔英.益血生胶囊联合琥珀酸亚铁治疗妊娠贫血的疗效观察[J].现代药物与临床,2021,36(6):1186-1189.
曹汉昌,牛锦龙.益血生治疗小儿营养性贫血50例[J].现代医药卫生,2002,18(1):51.
郑元胜,冷静.右旋糖酐铁口服液联合益血生胶囊治疗小儿缺铁性贫血疗效观察[J].吉林大学学报(医学版),2011,37(4):611.
姜海英,李馨蕊,李宪.益血生胶囊治疗子宫肌瘤并中度贫血的临床观察[J].中国社区医师,2019,35(2):109, 112.
CHENG Z, WU JL, CHEN JF. Clinical observation on the treatment of male neoplastic anemia with Yixuesheng capsule combined with recombination human erythropoietin [J]. Chin J Integr Med,2009,15(1):63-65.
汪洋畅,李勇飞,罗浩强,等.益血生胶囊治疗糖尿病肾病维持性血液透析的临床观察[J].北方药学,2021,18(4):57-58.
向彩春,曾礼华.益血生胶囊联合右旋糖酐铁治疗维持性血液透析患者贫血的疗效观察[J].现代中西医结合杂志,2011,20(1):52.
田国燕,顾磊,封爱英.益血生胶囊治疗恶性血液病化疗后骨髓抑制的疗效观察[J].中华中医药学刊,2016,34(2):505-507.
王娜,秦玲,刘珂.益血生胶囊联合DA化疗方案治疗急性髓系白血病临床研究[J].新中医,2020,52(19):108-110.
谢忠丽,杨堃,廖文娟.益血生胶囊治疗儿童急性白血病化疗后骨髓抑制临床研究[J].中国中医药现代远程教育,2021,19(20):91-93.
付岭,成雪,刘金梅.益血生胶囊对非霍奇金淋巴瘤患者化疗后免疫功能的影响[J].海南医学,2019,30(8):1039-1041.
曾祥学,张跃强,刘安家.益血生胶囊联合人粒细胞集落刺激因子治疗妇科肿瘤化疗后白细胞下降的临床研究[J].药物评价研究,2016,39(5):836-839.
吴慧忠,王巍.益血生胶囊联合利可君片治疗慢性乙型肝炎合并白细胞减少症的临床研究[J].中华中医药学刊,2017,35(10):2709-2711.
梁惠卿,吴耀南,杨嘉恩,等.益血生胶囊联合西药治疗慢性丙型病毒性肝炎40例临床观察[J].中医杂志,2015,56(16):1394-1397.
唐维,李宪.益血生改善药物相关性全血细胞减少症的效果[J].中国社区医师,2018,34(22):78-79.
0
浏览量
68
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构